Bilirubin oxidase as a solution for the interference of hyperbilirubinemia with ADAMTS-13 activity measurement by FRETS-VWF73 assay [5]

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 6, 2007, Pages 1330-1331

  Eckmann, C M ^a   de Laaf, R T M ^a   van Keulen, J M ^a   van Mourik, J A ^a,b,c   de Laat, Bas ^a,b  

^a Sanquin Diagnostiek   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BILIRUBIN OXIDASE; OXIDOREDUCTASE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

CLINICAL ARTICLE; CONTROLLED STUDY; COVARIANCE; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; DILUTION; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; HUMAN; HYPERBILIRUBINEMIA; INTERMETHOD COMPARISON; LETTER; PLASMA; PRIORITY JOURNAL; THROMBOTIC THROMBOCYTOPENIC PURPURA;

ADAM PROTEINS; BLOOD CHEMICAL ANALYSIS; HUMANS; HYPERBILIRUBINEMIA; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PLASMA EXCHANGE; PURPURA, THROMBOTIC THROMBOCYTOPENIC;

EID: 34250208476     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2007.02510.x     Document Type: Letter

References (8)

1. George JN. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-35.
2. Moschcowitz E. Hyaline thrombosis of the terminal arterioles and capillaries: A hitherto undescribed disease. Proc N Y Pathol Soc 1924; 24: 21-4.
3. Cal S, Obaya AJ, Llamazares M, Garabaya C, Quesada V, Lopez-Otin C. Cloning, expression analysis, and structural characterization of seven novel human ADAMTSs, a family of metalloproteinases with disintegrin and thrombospondin-1 domains. Gene 2002; 283: 49-62.
4. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B. von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 1998; 339: 1578-84.
5. Brunskill SJ, Tusold A, Benjamin S, Stanworth SJ, Murphy MF. A systematic review of randomized controlled trials for plasma exchange in the treatment of thrombotic thrombocytopenic purpura. Transfus Med 2007; 17: 17-35.
6. Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay. Br J Haematol 2005; 129: 93-100.
7. Meyer SC, Sulzer I, Lämmle B, Kremer Hovinga JA. Hyperbilirubinemia interferes with ADAMTS-13 activity measurement by FRETS-VWF73 assay -diagnostic relevance in patients suffering from acute thrombotic microangiopathies. J Thromb Haemost 2007; 5: 866-7.
8. Wong SS, Schenkel OJ. Quantification of plasma haemoglobin in the presence of bilirubin oxidase. Ann Clin Lab Sci 1995; 25: 247-51.